Daniel H. Sterman, MD
Adjunct Professor of Medicine (Pulmonary, Allergy and Critical Care)
Department: Medicine
Contact information
Pulmonary, Critical Care and Sleep Medicine
New York University School of Medicine
NYU Langone Medical Center
462 1st Avenue, OBV 605
New York, NY 10016
New York University School of Medicine
NYU Langone Medical Center
462 1st Avenue, OBV 605
New York, NY 10016
Office: 646-501-4181
Education:
A.B.
Brown University, 1985.
M.D.
Cornell University, 1989.
Permanent linkA.B.
Brown University, 1985.
M.D.
Cornell University, 1989.
Selected Publications
Zhu B, Chen P, Aminu M, Li JR, Fujimoto J, Tian Y, Hong L, Chen H, Hu X, Li C, Vokes N, Moreira AL, Gibbons DL, Solis Soto LM, Parra Cuentas ER, Shi O, Diao S, Ye J, Rojas FR, Vilar E, Maitra A, Chen K, Navin N, Nilsson M, Huang B, Heeke S, Zhang J, Haymaker CL, Velcheti V, Sterman DH, Kochat V, Padron WI, Alexandrov LB, Wei Z, Le X, Wang L, Fukuoka J, Lee JJ, Wistuba II, Pass HI, Davis M, Hanash S, Cheng C, Dubinett S, Spira A, Rai K, Lippman SM, Futreal PA, Heymach JV, Reuben A, Wu J, Zhang J.: Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception. Cancer Cell 43(6): 1125-1140, Jun 2025.Moore WH, Silk M, Bhattacharji P, Pua BB, Mammarappallil J, Sterman DH, Chachoua A.: Early experience with PEF in the setting of recalcitrant stage IV lung cancer. Lung Cancer 204: epub ahead of print, May 2025.
Goggin KE, Seo SJ, Wu BG, Ivelja S, Kugler MC, Chang M, Darawshy F, Li Y, Chung CJ, Kyeremateng Y, Tsay JJ, Singh S, Sterman DH, Segal LN, Egilmez NK, Li Q.: Differential Effects of High-Fiber and Low-Fiber Diets on Antitumor Immunity and Colon Tumor Progression in a Murine Model. Cancer Prev Res (Phila) 18(4): 223-234, Apr 2025.
Tsay JJ, Darawshy F, Wang C, Kwok B, Wong KK, Wu BG, Sulaiman I, Zhou H, Isaacs B, Kugler MC, Sanchez E, Bain A, Li Y, Schluger R, Lukovnikova A, Collazo D, Kyeremateng Y, Pillai R, Chang M, Li Q, Vanguri RS, Becker AS, Moore WH, Thurston G, Gordon T, Moreira AL, Goparaju CM, Sterman DH, Tsirigos A, Li H, Segal LN, Pass HI.: Lung Microbial and Host Genomic Signatures as Predictors of Prognosis in Early-Stage Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 33: 1433-1444, Nov 2024.
Azour L, Segal LN, Condos R, Moore WH, Landini N, Collazo D, Sterman DH, Young I, Ko J, Brosnahan S, Babb J, Chandarana H.: Low-field MRI lung opacity severity associated with decreased DLCO in post-acute Covid-19 patients. Clin Imaging 115: 110307 published on-line, Oct 2024.
Chen P, Rojas FR, Hu X, Serrano A, Zhu B, Chen H, Hong L, Bandyoyadhyay R, Aminu M, Kalhor N, Lee JJ, El Hussein S, Khoury JD, Pass HI, Moreira AL, Velcheti V, Sterman DH, Fukuoka J, Tabata K, Su D, Ying L, Gibbons DL, Heymach JV, Wistuba II, Fujimoto J, Solis Soto LM, Zhang J, Wu J.: Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma. Mod Pathol 36(12): 100326 published on-line, Dec 2023.
Dolgalev I, Zhou H, Murrell N, Le H, Sakellaropoulos T, Coudray N, Zhu K, Vasudevaraja V, Yeaton A, Goparaju C, Li Y, Sulaiman I, Tsay JJ, Meyn P, Mohamed H, Sydney I, Shiomi T, Ramaswami S, Narula N, Kulicke R, Davis FP, Stransky N, Smolen GA, Cheng WY, Cai J, Punekar S, Velcheti V, Sterman DH, Poirier JT, Neel B, Wong KK, Chiriboga L, Heguy A, Papagiannakopoulos T, Nadorp B, Snuderl M, Segal LN, Moreira AL, Pass HI, Tsirigos A.: Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nat Commun 14(1): 6764-6766, Nov 2023.
Sharpe AL, Reibman J, Oppenheimer BW, Goldring RM, Liu M, Shao Y, Bohart I, Kwok B, Weinstein T, Addrizzo-Harris D, Sterman DH, Berger KI.: Role of small airway dysfunction in unexplained exertional dyspnoea. ERJ Open Res 9(3): 00603-2022, Jun 2023.
Kwok B, Wu BG, Kocak IF, Sulaiman I, Schluger R, Li Y, Anwer R, Goparaju C, Ryan DJ, Sagatelian M, Dreier MS, Murthy V, Rafeq S, Michaud GC, Sterman DH, Bessich JL, Pass HI, Segal LN, Tsay JJ.: Pleural fluid microbiota as a biomarker for malignancy and prognosis. Sci Rep 13(1): 2229 published on-line, Feb 2023.
Brosnahan SB, Chen XJC, Chung J, Altshuler D, Islam S, Thomas SV, Winner MD, Greco AA, Divers J, Spiegler P, Sterman DH, Parnia S.: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. Ann Pharmacother 56(3): 237-244, Mar 2022.